ALL libraries (COBIB.SI union bibliographic/catalogue database)
  • 4,6- substituted-1,3,5-triazin-2(1H)-ones as monocyclic catalytic inhibitors of human DNA topoisomerase ▫$II\alpha$▫ targeting the ATP binding site
    Pogorelčnik, Barbara, 1985- ...
    Human DNA topoisomerase II[alpha] (htII[alpha]) is a validated target for the development of novel anticancer agents. Starting from our discovered 4-amino-1,3,5-triazine inhibitors of htII[alpha], we ... investigated a library of 2,4,6-trisubstituted-1,3,5-triazines for novel inhibitors that bind to the htII[alpha] ATP binding site using a combination of structure-based and ligand-basedpharmacophore models and molecular docking. 4,6-substituted-1,3,5-triazin-2(1H)-ones 8, 9 and 14 were identified as novel inhibitors with activity comparable to the established drug etoposide (1). Compound 8 inhibits the htII[alpha] decatenation in a superior fashion to etoposide.Cleavage assays demonstrated that selected compounds 8 and 14 do notact as poisons and antagonize the poison effect of etoposide. Microscale thermophoresis (MST) confirmed binding of compound 8 to the htII[alpha] ATPase domain and compound 14 effectively inhibits the htII[alpha] mediated ATP hydrolysis.The molecular dynamics simulation study provides further insight into the molecular recognition. The 4,6-disubstituted-1,3,5-triazin-2(1H)-ones represent the first validated monocyclic class of catalytic inhibitors that bind to the to the htII[alpha] ATPase domain.
    Source: Bioorganic & Medicinal Chemistry. - ISSN 0968-0896 (Vol. 23, iss. 15, Aug. 2015, str. 4218-4229)
    Type of material - article, component part ; adult, serious
    Publish date - 2015
    Language - english
    COBISS.SI-ID - 3886961

source: Bioorganic & Medicinal Chemistry. - ISSN 0968-0896 (Vol. 23, iss. 15, Aug. 2015, str. 4218-4229)
loading ...
loading ...
loading ...